Back to Search Start Over

Survival after surgical ablation for atrial fibrillation in mitral valve surgery : analysis from the Polish National Registry of Cardiac Surgery Procedures (KROK)

Authors :
Tomasz Hirnle
Jacek Pająk
Ryszard Jaszewski
Leszek Gryczko
Michał Wojtalik
Piotr Hendzel
Jerzy Sadowski
Paweł Bugajski
Janusz Stążka
Kazimierz Suwalski
Ryszard Stanisławski
Zdzislaw Tobota
Marian Zembala
Dariusz Borkowski
Krzysztof Jarmoszewicz
Maurycy Missima
Lech Anisimowicz
Maciej A. Karolczak
Stanisław Jabłonka
Romuald Cichon
Paweł Cholewiński
Mariusz Kowalewski
Janusz Skalski
Marek Jemielity
Bogusław Kapelak
Edward Pietrzyk
Mirosław Brykczyński
Wojciech Ogorzeja
Jan Rogowski
Bohdan Maruszewski
Wojciech Kustrzycki
Jacek Kaperczak
Piotr Stępiński
Piotr Żelazny
Ryszard Kalawski
Marek A. Deja
Michał Krejca
Marek Jasinski
Krzysztof Bartuś
Jacek Skiba
Łukasz Tułecki
Jacek Różański
Piotr Suwalski
Stanisław Woś
Jakub Staromłyński
Jacek J. Moll
Grzegorz Religa
Tadeusz Gburek
Wojciech Pawliszak
Mariusz Kuśmierczyk
Michał Zembala
Andrzej Biederman
Jarosław Jasiński
Inga Dziembowska
Paweł Kwinecki
Ireneusz Haponiuk
Kazimierz Widenka
Girish Sharma
Marek Cisowski
Antoni Dziatkowiak
Publication Year :
2019

Abstract

Surgical ablation for atrial fibrillation (AF) performed at the time of other valvular- or nonvalvular cardiac procedure is a mainstay of therapy; yet the data regarding its influence on remote survival are sparse. We aimed to evaluate late survival in patients undergoing mitral valve (MV) surgery with concomitant surgical ablation for AF.Procedure-related data from the Polish National Registry of Cardiac Surgery Procedures (Krajowy Rejestr Operacji Kardiochirurgicznych) were retrospectively collected. A total of 11,381 patients with baseline AF (46.6% men; mean age 65.6 ± 9.0 years) undergoing MV surgery between 2006 and 2017 in 37 reference centers across Poland and included in the registry were analyzed. Median follow-up was 5 years (mean, 4.6 years; interquartile range, 1.9-7.9 years). Cox proportional hazards models were used for computations. Propensity score matching for the comparison of MV + ablation versus MV alone was performed.Of included patients, 2449 (21.5%) underwent surgical ablation for AF. Patients in this group were significantly younger (63.8 ± 8.7 years vs 66.1 ± 9.0 years; P .001) and were at lower baseline surgical risk (EuroSCORE, 2.86 vs 3.69; P .001). During the 12-year study period, there was a significant survival benefit (hazard ratio, 0.71; 95% confidence interval, 0.63-0.79; P .001) for MV + ablation compared with MV alone. After rigorous propensity matching (logit model, 1784 pairs) surgical ablation was associated with nearly 20% improved survival (hazard ratio, 0.82; 95% confidence interval, 0.70-0.96; P = .011). Benefit of surgical ablation was maintained in subgroup analyses, yet most benefit was appraised in low-risk patients such as those with EuroSCORE of 2 to 5 or age 50 years.Concomitant surgical ablation for AF in patients undergoing mitral valve procedures is safe, feasible, and significantly improves late survival.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....3565c09971786ea39e8b4219c513508b